Motamed M, Osinubi O, Cook J A
Leicester Balance Centre, Department of Otolaryngology, Head and Neck Surgery, Leicester Royal Infirmary, Leicester, UK.
Laryngoscope. 2004 Jul;114(7):1296-8. doi: 10.1097/00005537-200407000-00029.
The canalith repositioning procedure (CRP), as described by Epley, is a well-established method of treatment for benign paroxysmal positional vertigo (BPPV). Debate exists as to whether simultaneous application of a mastoid oscillator confers any added benefit. The aim of this study was to examine this question.
Prospective randomized study.
Eighty-four subjects with unilateral posterior canal BPPV were randomized into two groups. The oscillator group was treated by CRP with mastoid oscillation and the nonoscillator group was treated by CRP alone. Positive outcome was regarded as complete resolution of symptoms and a negative Dix-Hallpike's test after a 4 to 6 week follow-up period.
Five patients were lost to follow-up. Twenty-eight (72%) patients from the oscillator group and 26 (65%) patients from the nonoscillator group had a positive outcome. This difference was not significant (chi = 0.17, P =.68)
For the treatment of posterior canal BPPV, concurrent mastoid oscillation with CRP does not significantly alter the short-term outcome.
埃普利描述的半规管结石复位法(CRP)是治疗良性阵发性位置性眩晕(BPPV)的一种成熟方法。对于同时应用乳突振荡器是否能带来额外益处存在争议。本研究的目的是探讨这个问题。
前瞻性随机研究。
84名单侧后半规管BPPV患者被随机分为两组。振荡器组采用CRP联合乳突振荡治疗,非振荡器组仅采用CRP治疗。随访4至6周后,症状完全缓解且Dix-Hallpike试验为阴性被视为阳性结果。
5名患者失访。振荡器组28例(72%)患者和非振荡器组26例(65%)患者获得阳性结果。这种差异不显著(χ² = 0.17,P = 0.68)。
对于后半规管BPPV的治疗,CRP联合乳突振荡不会显著改变短期疗效。